Market Closed -
NSE India S.E.
07:43:47 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
371.2
INR
|
+0.99%
|
|
+11.30%
|
+19.95%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
61,339
|
49,036
|
12,376
|
17,471
|
31,150
|
37,801
|
Enterprise Value (EV)
1 |
67,741
|
53,661
|
17,085
|
23,400
|
34,383
|
44,094
|
P/E ratio
|
24.8
x
|
15.1
x
|
6.02
x
|
36.9
x
|
76.1
x
|
17
x
|
Yield
|
0.07%
|
0.13%
|
0.51%
|
0.36%
|
0.27%
|
0.29%
|
Capitalization / Revenue
|
3.03
x
|
2.02
x
|
0.68
x
|
1.04
x
|
1.12
x
|
0.91
x
|
EV / Revenue
|
3.35
x
|
2.22
x
|
0.94
x
|
1.39
x
|
1.23
x
|
1.06
x
|
EV / EBITDA
|
15
x
|
9.55
x
|
5.77
x
|
18.3
x
|
21.7
x
|
10.6
x
|
EV / FCF
|
93.8
x
|
40.1
x
|
-85.3
x
|
-18.5
x
|
11.2
x
|
-7.68
x
|
FCF Yield
|
1.07%
|
2.49%
|
-1.17%
|
-5.41%
|
8.89%
|
-13%
|
Price to Book
|
4.34
x
|
3.01
x
|
0.71
x
|
0.97
x
|
1.67
x
|
1.66
x
|
Nbr of stocks (in thousands)
|
418,408
|
418,579
|
418,808
|
418,965
|
418,965
|
432,707
|
Reference price
2 |
146.6
|
117.2
|
29.55
|
41.70
|
74.35
|
87.36
|
Announcement Date
|
9/5/18
|
5/28/19
|
9/2/20
|
9/2/21
|
9/5/22
|
5/29/23
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
20,215
|
24,224
|
18,106
|
16,795
|
27,913
|
41,718
|
EBITDA
1 |
4,524
|
5,620
|
2,962
|
1,276
|
1,583
|
4,148
|
EBIT
1 |
4,192
|
5,281
|
2,605
|
848.2
|
1,142
|
3,690
|
Operating Margin
|
20.74%
|
21.8%
|
14.39%
|
5.05%
|
4.09%
|
8.85%
|
Earnings before Tax (EBT)
1 |
3,610
|
4,621
|
1,941
|
645.6
|
534.7
|
2,802
|
Net income
1 |
2,475
|
3,243
|
2,055
|
474.8
|
409.5
|
2,160
|
Net margin
|
12.24%
|
13.39%
|
11.35%
|
2.83%
|
1.47%
|
5.18%
|
EPS
2 |
5.914
|
7.740
|
4.908
|
1.130
|
0.9773
|
5.130
|
Free Cash Flow
1 |
721.9
|
1,338
|
-200.3
|
-1,266
|
3,057
|
-5,745
|
FCF margin
|
3.57%
|
5.52%
|
-1.11%
|
-7.54%
|
10.95%
|
-13.77%
|
FCF Conversion (EBITDA)
|
15.96%
|
23.8%
|
-
|
-
|
193.14%
|
-
|
FCF Conversion (Net income)
|
29.17%
|
41.25%
|
-
|
-
|
746.6%
|
-
|
Dividend per Share
2 |
0.1000
|
0.1500
|
0.1500
|
0.1500
|
0.2000
|
0.2500
|
Announcement Date
|
9/5/18
|
5/28/19
|
9/2/20
|
9/2/21
|
9/5/22
|
5/29/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
6,402
|
4,624
|
4,709
|
5,929
|
3,233
|
6,293
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.415
x
|
0.8227
x
|
1.59
x
|
4.647
x
|
2.042
x
|
1.517
x
|
Free Cash Flow
1 |
722
|
1,338
|
-200
|
-1,266
|
3,057
|
-5,745
|
ROE (net income / shareholders' equity)
|
20.3%
|
21.3%
|
12.2%
|
2.68%
|
2.14%
|
10.4%
|
ROA (Net income/ Total Assets)
|
11%
|
12.7%
|
6.09%
|
1.98%
|
2.29%
|
6.47%
|
Assets
1 |
22,488
|
25,566
|
33,763
|
23,975
|
17,910
|
33,391
|
Book Value Per Share
2 |
33.80
|
39.00
|
41.40
|
42.80
|
44.60
|
52.70
|
Cash Flow per Share
2 |
0.4800
|
0.3400
|
1.000
|
1.260
|
4.140
|
4.800
|
Capex
1 |
628
|
2,038
|
2,467
|
350
|
232
|
825
|
Capex / Sales
|
3.11%
|
8.41%
|
13.63%
|
2.08%
|
0.83%
|
1.98%
|
Announcement Date
|
9/5/18
|
5/28/19
|
9/2/20
|
9/2/21
|
9/5/22
|
5/29/23
|
|
1st Jan change
|
Capi.
|
---|
| +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|